Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hoth Therapeutics Inc (NQ: HOTH )

0.8400 +0.0092 (+1.11%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hoth Therapeutics Inc

< Previous 1 2 3 4 5 6 7 Next >
Stocks That Hit 52-Week Lows On Friday
  During Friday, 125 stocks hit new 52-week lows. 
Via Benzinga
Hoth Therapeutics Shares Surge On Encouraging Preclinical Data From Alzheimer's Program
Via Benzinga
Hoth Therapeutics Adds New Pipeline Program For Stroke, Brain Injury
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 53 companies reached new 52-week lows. 
Via Benzinga
Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. 
Via Benzinga
S&P 500 Rises Over 1%; General Motors Earnings Top Views
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday. 
Via Benzinga
Why Fulgent Genetics Shares Are Trading Higher Today
Via Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 120 companies set new 52-week lows. 
Via Benzinga
Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene... 
Via Benzinga
Why Hoth Therapeutics Shares Are Falling In Monday's After-Hours Session
Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading lower by 11.12% to $0.29 during Monday's after-hours session after the company  
Via Benzinga
Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around... 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
U.S. Stocks Turn Higher; PepsiCo Posts Upbeat Q2 Results
U.S. stocks turned higher midway through trading after recording losses in the previous session. 
Via Benzinga
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Why Hoth Therapeutics Shares Are Skyrocketing Today
Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher by 17% to $0.47 Tuesday morning after the company announced its HT-ALZ therapeutic showed cognitive improvements in an Alzheimer's Disease... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of their outstanding shares is at $47.6 million. As per the press... 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
Via Benzinga
InvestorNewsBreaks – Hoth Therapeutics Inc. (NASDAQ: HOTH) Shares Pricing of $7M Public Offering
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
Hoth Therapeutics Plunges Afterhours On Secondary Public Offering Of Common Stock
Hoth Therapeutics Inc (NASDAQ: HOTH) says it has commenced an underwritten public offering. Details were not disclosed. The company's proposed offering of the... 
Via Benzinga
These 8 Stocks Are Seeing Massive Volume Today
Trading volume is a simple way to measure how much of a security is being traded over a period of time. A high trading volume indicates high buying pressure if the stock is moving higher, or high... 
Via Benzinga
Why Is SoFi (SOFI) Stock Down to New 52-Week Lows Today?
SoFi Technologies (SOFI) stock isn't doing so well on Monday after the stock dropped to a new 52-week low and we know why! 
Via InvestorPlace
Is WBD Stock a Buy? 3 Analysts Weigh In on Warner Bros. Discovery.
Warner Bros. Discovery (WBD) stock is on the move today following the merger between Warner Bros. and Discovery last week. 
Via InvestorPlace
Why Is Hoth Therapeutics (HOTH) Stock Skyrocketing 110% Today?
Hoth Therapeutics (HOTH) stock is rising higher on Monday after the biopharmaceutical company provided an update on HT-KIT. 
Via InvestorPlace
Hoth Therapeutics' Novel Cancer Drug Prevented Cell Growth, Induced Cell Death Over 72 hours
Hoth Therapeutics Inc (NASDAQ: HOTH) shares are surging after  
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.